Naltrexone implant (BioCorRx)

纳曲酮植入剂 (BioCorRx)

Report date: 2026/05/14 20:00:28

Base Information

Drug NameNaltrexone implant (BioCorRx)
Drug Alias Name盐酸纳曲酮植入剂BICX-104BICX-102
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors antagonists
TargetsOpioid receptors
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Opioid-Related Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBioCorRx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Opioid-Related Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A